Cinctive Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-210,000
Closed -$15.6M 436
2025
Q4
$15.6M Buy
210,000
+143,596
+216% +$10.5M 0.85% 24
2025
Q3
$4.48M Buy
66,404
+23,119
+53% +$1.53M 0.21% 161
2025
Q2
$2.82M Buy
+43,285
New +$2.59M 0.15% 181
2024
Q1
Sell
-18,148
Closed -$1.3M 446
2023
Q4
$1.3M Buy
+18,148
New +$1.26M 0.09% 224
2023
Q2
Sell
-106,664
Closed -$8.61M 422
2023
Q1
$8.61M Buy
+106,664
New +$8.59M 0.29% 115
2020
Q4
Sell
-104,292
Closed -$6.93M 363
2020
Q3
$6.93M Buy
104,292
+35,816
+52% +$2.27M 0.61% 43
2020
Q2
$3.9M Buy
68,476
+15,031
+28% +$738K 0.45% 80
2020
Q1
$1.88M Buy
+53,445
New +$2.54M 0.42% 100

Other funds holding HOLX

Cinctive Capital Management's HOLX Position: Q1 2026 in Review

Cinctive Capital Management sold out of Hologic (HOLX) in Q1 2026, closing a stake of 210,000 shares — an estimated $15.6M sold.

Cinctive Capital Management first reported a position in HOLX in Q1 2020 and held it in 8 quarters. The position peaked at $15.6M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Cinctive Capital Management reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 210,000 Hologic shares in Q1 2026, an estimated $15.6M.
  • Cinctive Capital Management first reported a position in Hologic in Q1 2020 and held it in 8 quarters.
  • Cinctive Capital Management's Hologic position peaked at $15.6M in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.